Home / Medical Devices / Drug Eluting Stents Market By Product (Polymer Based Coating, Polymer Free Coating), By Application (Peripheral Artery Disease, Coronary Artery Disease) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Drug Eluting Stents Market By Product (Polymer Based Coating, Polymer Free Coating), By Application (Peripheral Artery Disease, Coronary Artery Disease) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Published: Dec 2017 | Report Code: 58866-12-17

World Health Organization in its 2015 statistics has reported that out of the 17 million premature deaths 82 % of the deaths were from the lower and middle income countries, and 37 % of these were due to cardiovascular diseases. The risk factors identified to be associated to the worsening of the disease etiology related to cardiac complications are, binge drinking, smoking, obesity and type 2 diabetes. It is noteworthy to understand that there are no symptoms in the blood vessel diseases, a heart attack or stroke are considered as warning for the underlying diseases. Drug eluting stents finds importance in the cardiovascular complications as it is a minimally invasive surgical procedure, broadens the constricted blood vessels, and is useful in prolonging the life of the patient.

Polymer based coating and polymer free coating has been included in the product segment. Polymer based coating is further sub segmented as non-biodegradable and biodegradable polymer based coatings. Polymer free coating comprises of micro porous surface, microstructured surface, slotted tubular surface and nanoporous surface. The application segment comprises of periphery artery disease and coronary artery disease. With respect to the scope of report market estimation and forecast for the duration 2015-2025 is included in the report.

Major countries showcasing the drug eluting stents market in their respective geographical regions are segmented as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market sizing and data forecast for the country cross sectional has been covered in the scope of the report.

Porter’s five forces model has been included in the scope of the report which give a holistic view regarding the market dynamics prevalent in the drug eluting stents market. Competitive landscape is a very useful study which gives insights regarding the competition faced by the major companies trying to gain a strong foothold in the drug eluting stents market.  The major players in global Drug Eluting Stents market are Stentys, Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation and Shandong JW Medical Systems.

Drug Eluting Stents Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Drug Eluting Stents Market Portraiture
2.1.1. Global Drug Eluting Stents Market, by Product, 2016 (Value %)
2.1.2. Global Drug Eluting Stents Market, by Application, 2016 (Value %)
2.1.3. Global Drug Eluting Stents Market, by Geography, 2016 (Value %)

Chapter 3. Drug Eluting Stents Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography
3.7. Top 3 Countries: Global Drug Eluting Stents Market, 2015-2025 (US$ Mn)
3.8. Competitive Landscape : Global Drug Eluting Stents Market, by Key Players 2015-2025 (US$ Mn)

Chapter 4. Global Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Drug Eluting Stents Market, by Product, 2016
4.3. Polymer Based Coating
4.3.1. Non-Biodegradable Polymer Based
4.3.2. Biodegradable Polymer Based
4.4. Polymer Free Coating
4.4.1. Micro Porous Surface
4.4.2. Microstructured Surface
4.4.3. Slotted Tubular Surface
4.4.4. Nanoporous Surface

Chapter 5. Global Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Drug Eluting Stents Market, by Application, 2016
5.2. Peripheral Artery Disease
5.3. Coronary Artery Disease

Chapter 6. Global Drug Eluting Stents Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Drug Eluting Stents Market Analysis, 2015 – 2025
6.2.1. North America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Drug Eluting Stents Market Analysis, 2015 – 2025
6.3.1. Europe Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Drug Eluting Stents Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of Asia Pacific
6.5. Latin America Drug Eluting Stents Market Analysis, 2015 – 2025
6.5.1. Latin America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Drug Eluting Stents Market Analysis, 2015 – 2025
6.6.1. Middle East and Africa Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. Middle East and Africa Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. Middle East and Africa Drug Eluting Stents Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of Middle East and Africa

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Biosensors International Group
7.3. Biotronik
7.4. Boston Scientific Corporation
7.5. Cook Medical
7.6. Lepu Medical Technology
7.7. Medtronics Plc
7.8. Terumo Medical Corporation
7.9. Shandong JW Medical Systems
7.10. Stentys

List Of Table :

TABLE 1 Global Drug Eluting Stents Market Portraiture
TABLE 2 Global Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 3 Global Polymer Based Coating Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 4 Global Polymer Free Coating Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 5 Global Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 Global Drug Eluting Stents Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 8 North America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 North America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Drug Eluting Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Drug Eluting Stents Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 22 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Biosensors International Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Biotronik: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Cook Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Lepu Medical Technology: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Medtronics Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Terumo Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Shandong JW Medical Systems: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Stentys: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List Of Figures :

FIG. 1 Drug Eluting Stents: Market Segmentation
FIG. 2 Global Drug Eluting Stents Market Share, by Product, 2016 (Value %)
FIG. 3 Global Drug Eluting Stents Market, by Application, 2016 (Value %)
FIG. 4 Global Drug Eluting Stents Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Non-Biodegradable Polymer Based Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Biodegradable Polymer Based Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Micro Porous Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Microstructured Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Slotted Tubular Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Nanoporous Surface Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Peripheral Artery Disease Market for Drug Eluting Stents, 2015 – 2025 (US$ Mn)
FIG. 14 Global Coronary Artery Disease Market for Drug Eluting Stents, 2015 – 2025 (US$ Mn)
FIG. 15 U.S. Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 16 Canada Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 17 U.K. Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 18 Germany Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 19 Rest of Europe Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 20 Japan Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 21 China Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 22 India Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest of Asia Pacific Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 24 Brazil Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 25 Mexico Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest of Latin America Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 27 GCC Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Middle East and Africa Drug Eluting Stents Market, 2015 – 2025 (US$ Mn)

Based on product, the global drug eluting stents market is categorized into

  • Polymer Based Coating
    • Non-Biodegradable Polymer Based
    • Biodegradable Polymer Based
  • Polymer Free Coating
    • Micro Porous Surface
    • Microstructured Surface
    • Slotted Tubular Surface
    • Nanoporous Surface

Drug Eluting Stents Market

Atherosclerotic plaques comprises of cholesterol, fat, calcium and other inflammatory substances present in the blood usually builds up in the arteries. It is of prime importance to understand the fatal outcomes of untreated atherosclerotic plaques which may lead to stroke, heart attack, and death in severe cases. Polymer free coating stents shows market domination as it has faster drug elution rate. Microporous surface stent is gaining tremendous demand due to its reduction in the in-stent restenosis. Nanoporous surface has excellent features such as higher drug loading capacity and hence drives the polymer free coating stents market.  Polymer based coating are gaining good momentum as it is useful in addressing the problems of local inflammation and neointima hyperplasia by suppressing them and also providing sustained and controlled drug release for a longer period of time. The major players in drug eluting stents market are Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation, Shandong JW Medical Systems and Stentys.

Based on application, the global drug eluting stents market is categorized into

  • Peripheral Artery Disease
  • Coronary Artery Disease

Drug Eluting Stents Market

According to the World Health Organization cardiovascular diseases are one of the prime causes of global deaths accounting for 17.7 million deaths each year which represents 31 % of the deaths worldwide. Increased consumption of fast food, profound smoking habit, obesity and stress accounts for the morbidity due to stroke, and heart attacks. It is noteworthy that 80 % of all the cardiovascular deaths are due to either stroke or heart attacks which occur due to narrowing of arteries due to atherosclerotic plaques causing hypertension and reduced supply of oxygen. Coronary artery disease is most prevalent condition in cardiovascular complications due to increasing number of patients suffering with type-2 diabetes, excessive alcohol consumption, high levels of C reactive proteins, and consumption of poor diet deficient in vitamin E, D and C. Peripheral artery disease is precipitating at a faster pace as the blockage of arteries in the proximities causes claudication while walking and climbing, erectile dysfunction in men, and sores and wounds of the feet that heal poorly.

For the purpose of this study, the global drug eluting stents market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Drug Eluting Stents Market

North American dominance is related to the rising prevalence of cardiovascular disease. The American Heart Association in its Heart Disease and Strokes Statistics 2017 has reported that cardiovascular disease is responsible for the deaths of around 800,000 U.S. citizens which is equivalent to one in every three deaths. Sedentary lifestyle, rising consumption of saturated food products contributes towards growth of North America drug eluting stents market. The European market is driven by the rising prevalence of type 2 diabetes and obesity. The presence of pharmaceutical companies manufacturing drug eluting stents represent Europe’s market growth for drug eluting stents. Presence of baby boomer population with cardiovascular complications, increasing public health awareness, and supportive regulatory environment for drug eluting stents drive the Asia Pacific Market. Enhanced Government spending in establishment of developed healthcare centers and foreign direct investment by healthcare medical device manufacturers will have an impressive growth for drug eluting stents market in the Middle East and Africa and Latin America.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients